Antacid recalls
The FDA has published 3 recalls involving Antacid since 2014. The latest was reported on 15 Jun 2022. Most were for potency & assay. L. Perrigo has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 15 Jun 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 67%Class III 1 33%
Why antacid is recalled
Companies
By year
All antacid recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | E-Z-Gas II, Effervescent Granules recalled by Mckesson Medical-SurgicalE-z-gas | Mckesson Medical-Surgical Inc. Corporate Office | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Antacid Tablets, Calcium Carbonate chewable tablets, 750mg recalled | L. Perrigo | Particulate Matter | Nationwide |
| Drug | CLASS III | E-z- Gas II Effervescent Granules Antacid/Antiflatulent recalledE-z-gas | Bracco Diagnostic | Potency & Assay | Nationwide |
Should you stop taking Antacid?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.